Agilent Technologies stock gains as FDA-cleared S540MD slide scanner strengthens digital pathology push

Agilent Technologies (ISIN US00846U1016) stock recently closed at 150.86 USD as of September 5, 2026, supported by rising demand for its life-science tools and a fresh U.S. launch of the FDA-cleared S540MD Slide Scanner System in digital pathology, according to Simply Wall St and Business Wire data.

Digital pathology launch backs recent momentum

According to a Business Wire release dated September 4, 2026, Agilent Technologies announced the U.S. launch of the Agilent S540MD Slide Scanner System after receiving FDA clearance for the whole slide imaging device used in high-throughput digital pathology workflows.

The S540MD Slide Scanner broadens Agilent Technologies digital pathology portfolio and is aimed at helping clinical laboratories increase diagnostic efficiency and handle rising case volumes, according to the same Business Wire report dated September 4, 2026.

Share performance and valuation context

As highlighted by a Simply Wall St analysis updated September 5, 2026, Agilent Technologies shares delivered a 30 day share price return of 6.91 percent and a 90 day share price return of 11.39 percent, while the one year total shareholder return stood at 18.11 percent, illustrating sustained investor interest.

The same Simply Wall St overview notes that Agilent Technologies last closed at 150.86 USD compared with an estimated narrative fair value of 174.90 USD, suggesting a valuation gap that analysts are attempting to bridge through assumptions about earnings, margins and growth.

Representative product: S540MD Slide Scanner System

In digital pathology, the newly launched Agilent S540MD Slide Scanner System is a whole slide imaging platform intended for high-throughput workflows in clinical laboratories, following FDA clearance in the U.S., according to Business Wire on September 4, 2026.

Stock level and investor takeaway

Agilent Technologies stock, trading on the New York Stock Exchange under the ticker A, closed at 150.86 USD as of September 5, 2026, a level that sits below some fair-value estimates but reflects a positive 30 day and 90 day share-price performance trend highlighted by Simply Wall St.